We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$609M
AUM Growth
+$26.8M
Cap. Flow
-$8.71M
Cap. Flow %
-1.43%
Top 10 Hldgs %
24.48%
Holding
236
New
21
Increased
96
Reduced
91
Closed
20

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.43M
2
CTLT
CATALENT, INC.
CTLT
+$3.77M
3
L icon
Loews
L
+$3.23M
4
PYPL icon
PayPal
PYPL
+$3.08M
5
GNRC icon
Generac Holdings
GNRC
+$3.03M

Sector Composition

Rank Sector Weight
1 Healthcare 17.81%
2 Technology 14.92%
3 Industrials 7.34%
4 Communication Services 7.31%
5 Energy 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
101
Newmont
NEM
$124B
$1.13M 0.18%
23,861
+601
+3% +$26.8K
T icon
102
AT&T
T
$166B
$1.13M 0.18%
61,115
+2,466
+4% +$44.1K
APA icon
103
APA Corp
APA
$14B
$1.08M 0.18%
23,153
-2,118
-8% -$94.8K
RIO icon
104
Rio Tinto
RIO
$165B
$1.08M 0.18%
15,115
+2,331
+18% +$146K
XLI icon
105
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$1.02M 0.17%
10,406
-4,408
-30% -$420K
CTLP
106
DELISTED
Cantaloupe
CTLP
$1.01M 0.17%
232,145
+37,245
+19% +$132K
EXP icon
107
Eagle Materials
EXP
$6.47B
$1.01M 0.17%
7,597
+40
+0.5% +$5.05K
MODN
108
DELISTED
MODEL N, INC.
MODN
$1M 0.16%
24,770
-45
-0.2% -$1.69K
KMB icon
109
Kimberly-Clark
KMB
$36.2B
$988K 0.16%
7,280
+389
+6% +$49.4K
LMT icon
110
Lockheed Martin
LMT
$140B
$979K 0.16%
2,011
+38
+2% +$17.7K
CDMO
111
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$966K 0.16%
70,158
+7,011
+11% +$107K
FIX icon
112
Comfort Systems
FIX
$61.2B
$940K 0.15%
8,168
-1,287
-14% -$150K
DGII icon
113
Digi International
DGII
$3.23B
$939K 0.15%
25,695
-10,084
-28% -$388K
JHG
114
DELISTED
Janus Henderson
JHG
$927K 0.15%
39,405
+584
+2% +$13.7K
KEX icon
115
Kirby Corp
KEX
$7.18B
$922K 0.15%
14,334
+25
+0.2% +$1.67K
ON icon
116
ON Semiconductor
ON
$32.4B
$922K 0.15%
14,780
-6,111
-29% -$408K
EWW icon
117
iShares MSCI Mexico ETF
EWW
$1.9B
$918K 0.15%
+18,571
New +$935K
INFU icon
118
InfuSystem Holdings
INFU
$244M
$914K 0.15%
105,270
+1,640
+2% +$13.4K
SCCO icon
119
Southern Copper
SCCO
$165B
$905K 0.15%
16,357
-160
-1% -$8.07K
PBR icon
120
Petrobras
PBR
$114B
$903K 0.15%
84,796
+14,242
+20% +$172K
MGNI icon
121
Magnite
MGNI
$3.49B
$891K 0.15%
84,182
+103
+0.1% +$940
IWV icon
122
iShares Russell 3000 ETF
IWV
$20.4B
$881K 0.14%
3,992
UCTT
123
Ultra Clean Holdings
UCTT
$4.1B
$876K 0.14%
26,439
+122
+0.5% +$3.89K
ENV
124
DELISTED
ENVESTNET, INC.
ENV
$859K 0.14%
13,916
-71
-0.5% -$3.78K
MTZ icon
125
MasTec
MTZ
$22.6B
$858K 0.14%
10,051
+120
+1% +$9.84K

Similar funds

Greenwood Capital Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Greenwood Capital Associates held 236 positions worth $609M, up 4.6% from $583M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Greenwood Capital Associates's Q4 2022 filing shows 21 new, 96 increased, 91 reduced and 20 closed positions. Its largest new stake was iShare MSCI Eurozone ETF: 143,256 shares worth $5.66M. The largest sale was Medtronic, an estimated $4.43M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Greenwood Capital Associates's largest Q4 2022 buy was iShare MSCI Eurozone ETF: 143,256 shares worth $5.66M.
  • Greenwood Capital Associates added most to Chart Industries in Q4 2022, an estimated $5.03M increase.
  • Greenwood Capital Associates's biggest Q4 2022 reduction was Medtronic, cutting an estimated $4.43M.
  • Greenwood Capital Associates fully exited CATALENT, INC. in Q4 2022, selling an estimated $3.77M.
  • Greenwood Capital Associates's ten largest holdings make up 24% of its $609M portfolio in Q4 2022.
  • Greenwood Capital Associates opened 21 new positions and closed 20 in Q4 2022.
  • Greenwood Capital Associates's portfolio value rose 4.6% quarter-over-quarter to $609M.

Based on Greenwood Capital Associates's 13F filing for Q4 2022, filed 26 Jan 2023.